ClearPoint Neuro wins FDA clearance for neuro laser therapy accessory

ClearPoint Neuro (Nasdaq:CLPT) announced today that the FDA granted 510(k) clearance for its Prism bone anchor accessory.

It marks the second new product introduction in 2024 for the company, with its stereotactic guidance system garnering clearance in January.

The Prism system features the only non-cooled laser applicator on the market, the company said. Its next-generation laser applicator technology eliminates the need for external cooling. This simplifies setup, reduces power and ablation time and lessens imaging artifact for more efficient workflows.

Sign up for Blog Updates